Oncolytics Biotech Inc.

General ticker "ONCY" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $71.7M (TTM average)

Oncolytics Biotech Inc. follows the US Stock Market performance with the rate: 43.4%.

Estimated limits based on current volatility of 3.8%: low 1.00$, high 1.08$

Factors to consider:

  • Earnings expected soon, date: 2026-03-06 bmo
  • Total employees count: 9 as of 2002
  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [0.62$, 1.64$]
  • 2025-12-31 to 2026-12-31 estimated range: [0.69$, 1.76$]

Financial Metrics affecting the ONCY estimates:

  • Positive: with PPE of -3.0 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -27.42 <= 0.01
  • Positive: Investing cash flow per share per price, % of -0.24 > -0.63
  • Positive: 19.40 < Shareholder equity ratio, % of 29.64 <= 42.68
  • Positive: Inventory ratio change, % of 0 <= 0
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term ONCY quotes

Long-term ONCY plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue CA$0.00MM CA$0.00MM CA$0.00MM
Operating Expenses CA$20.68MM CA$25.04MM CA$34.98MM
Operating Income CA$-20.68MM CA$-25.04MM CA$-34.98MM
Non-Operating Income CA$1.67MM CA$4.55MM CA$3.40MM
R&D Expense CA$11.85MM CA$13.12MM CA$21.65MM
Income(Loss) CA$-19.01MM CA$-20.49MM CA$-31.58MM
Taxes CA$0.06MM CA$0.07MM CA$0.13MM
Profit(Loss)* CA$-24.84MM CA$-27.75MM CA$-31.71MM
Stockholders Equity CA$26.50MM CA$27.56MM CA$5.98MM
Assets CA$37.33MM CA$38.82MM CA$20.19MM
Operating Cash Flow CA$-23.36MM CA$-28.45MM CA$-26.97MM
Capital expenditure CA$0.06MM CA$0.01MM CA$0.24MM
Investing Cash Flow CA$-20.40MM CA$20.22MM CA$-0.24MM
Financing Cash Flow CA$12.21MM CA$31.99MM CA$6.64MM
Earnings Per Share** CA$-0.43 CA$-0.41 CA$-0.41

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.